The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function
- PMID:15342424
- DOI: 10.1158/0008-5472.CAN-04-0338
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function
Abstract
The ADP-ribosyltransferase (ADPRT) gene encodes a zinc-finger DNA-binding protein, poly(ADP-ribose) polymerase-1 (PARP-1), that modifies various nuclear proteins by poly(ADP-ribosyl)ation and functions as a key enzyme in the base excision repair pathway. We have conducted two studies to test whether an amino acid substitution variant, ADPRT V762A (T2444C), is associated with prostate cancer (CaP) risk and decreased enzyme function. The first study used genomic DNA samples from an ongoing, clinic-based case-control study (488 cases and 524 controls) to show that a higher percentage of the CaP cases carried the ADPRT 762 AA genotype than controls (4% versus 2%). In Caucasians, the AA genotype was significantly associated with increased CaP risk [odds ratio (OR), 2.65; 95% confidence interval (CI), 1.08-6.49], and the VA genotype was associated with a slight but not significantly increased CaP risk (OR, 1.18; 95% CI, 0.85-1.64) using VV as the referent group after adjustment for age, benign prostatic hyperplasia, and family history. Furthermore, this association was stronger in younger (<65) men (OR, 4.77; 95% CI, 1.01-22.44) than older (> or =65) men (OR, 1.78; 95% CI, 0.55-5.82). The second study used freshly isolated peripheral lymphocytes from 354 cancer-free subjects to demonstrate that the ADPRT 762 A allele contributed to significantly lower adenosine diphosphate ribosyl transferase (ADPRT)/PARP-1 activities in response to H2O2 in a gene dosage-dependent manner (P < 0.0001, test for linear trend). The PARP-1 activities (mean +/- SD dpm/10(6) cells) were 18,554 +/- 9,070 (n=257), 14,847 +/- 7,082 (n=86), and 12,155 +/- 6,334 (n=11) for VV, VA, and AA genotypes, respectively. This study is the first to provide evidence that the ADPRT V762A-genetic variant contributes to CaP susceptibility and altered ADPRT/PARP-1 enzyme function in response to oxidative damage.
Similar articles
- Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer.Zhang X, Miao X, Liang G, Hao B, Wang Y, Tan W, Li Y, Guo Y, He F, Wei Q, Lin D.Zhang X, et al.Cancer Res. 2005 Feb 1;65(3):722-6.Cancer Res. 2005.PMID:15705867
- Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer.Miao X, Zhang X, Zhang L, Guo Y, Hao B, Tan W, He F, Lin D.Miao X, et al.Gastroenterology. 2006 Aug;131(2):420-7. doi: 10.1053/j.gastro.2006.05.050.Gastroenterology. 2006.PMID:16890595
- The Ala allele at Val762Ala polymorphism in poly(ADP-ribose) polymerase-1 (PARP-1) gene is associated with a decreased risk of asthma in a Turkish population.Tezcan G, Gurel CB, Tutluoglu B, Onaran I, Kanigur-Sultuybek G.Tezcan G, et al.J Asthma. 2009 May;46(4):371-4. doi: 10.1080/02770900902777791.J Asthma. 2009.PMID:19484672
- [Poly(ADP-ribose) polymerase-1 as a regulator of protein-nucleic acid interactions in the processes responding to genotoxic action].Sukhanova MV, Lavrik OI, Khodyreva SN.Sukhanova MV, et al.Mol Biol (Mosk). 2004 Sep-Oct;38(5):834-47.Mol Biol (Mosk). 2004.PMID:15554186Review.Russian.
- Probable macromolecular mechanisms of gene regulation by adenosine diphosphoribosyl transferase (ADPRT).Kun E.Kun E.Adv Exp Med Biol. 1988;231:613-26. doi: 10.1007/978-1-4684-9042-8_51.Adv Exp Med Biol. 1988.PMID:3137790Review.No abstract available.
Cited by
- Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.Curtin NJ, Szabo C.Curtin NJ, et al.Mol Aspects Med. 2013 Dec;34(6):1217-56. doi: 10.1016/j.mam.2013.01.006. Epub 2013 Jan 29.Mol Aspects Med. 2013.PMID:23370117Free PMC article.Review.
- The joint effect of hOGG1, APE1, and ADPRT polymorphisms and cooking oil fumes on the risk of lung adenocarcinoma in Chinese non-smoking females.Xue X, Yin Z, Lu Y, Zhang H, Yan Y, Zhao Y, Li X, Cui Z, Yu M, Yao L, Zhou B.Xue X, et al.PLoS One. 2013 Aug 12;8(8):e71157. doi: 10.1371/journal.pone.0071157. eCollection 2013.PLoS One. 2013.PMID:23951099Free PMC article.
- Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.Yin M, Liao Z, Liu Z, Wang LE, Gomez D, Komaki R, Wei Q.Yin M, et al.Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e67-73. doi: 10.1016/j.ijrobp.2010.11.079. Epub 2011 Mar 21.Int J Radiat Oncol Biol Phys. 2011.PMID:21420246Free PMC article.
- Association between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies.Hua RX, Li HP, Liang YB, Zhu JH, Zhang B, Ye S, Dai QS, Xiong SQ, Gu Y, Sun XZ.Hua RX, et al.PLoS One. 2014 Jan 28;9(1):e87057. doi: 10.1371/journal.pone.0087057. eCollection 2014.PLoS One. 2014.PMID:24489833Free PMC article.
- PARP-1 regulates epithelial-mesenchymal transition (EMT) in prostate tumorigenesis.Pu H, Horbinski C, Hensley PJ, Matuszak EA, Atkinson T, Kyprianou N.Pu H, et al.Carcinogenesis. 2014 Nov;35(11):2592-601. doi: 10.1093/carcin/bgu183. Epub 2014 Aug 30.Carcinogenesis. 2014.PMID:25173886Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous